Undersulfated and Glycol-Split Heparins Endowed with Antiangiogenic Activity

Journal of Medicinal Chemistry

Volumn 47, Issue 4, 2004, Pages 838-848

  Casu, Benito ^a   Guerrini, Marco ^a   Guglieri, Sara ^a   Naggi, Annamaria ^a   Perez, Marta ^a   Torri, Giangiacomo ^a   Cassinelli, Giuseppe ^a   Ribatti, Domenico ^b   Carminati, Paolo ^c   Giannini, Giuseppe ^c   Penco, Sergio ^c   Pisano, Claudio ^c   Belleri, Mirella ^d   Rusnati, Marco ^d   Presta, Marco ^d  

^a Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c Sigma Tau SpA   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; GLYCOL; HEPARIN DERIVATIVE; PROTEOHEPARAN SULFATE;

AMINATION; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CALCULATION; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIS; COMPLEX FORMATION; EMBRYO; ENDOTHELIUM CELL; MOLECULAR DYNAMICS; NONHUMAN;

ALLANTOIS; ANGIOGENESIS INHIBITORS; ANIMALS; CATTLE; CELL ADHESION; CELL DIVISION; CHICK EMBRYO; CHORION; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GLYCOLS; HEPARIN; MODELS, MOLECULAR; PROTEOGLYCANS; RECEPTORS, FIBROBLAST GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONIC ACIDS; URONIC ACIDS;

EID: 10744225880     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030893g     Document Type: Article

References (49)

1. Kerbel, R.; Folkman, J. Clinical translation of angiogenesis inhibitors. Nature Rev./Cancer 2002, 2, 727-739.
2. Bernfield, M.; Gotte, M.; Park, P. W. Function of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 1999, 68, 729-777.
3. Iozzo, R. V.; San Antonio, J. D. Heparan sulfate proteoglycans: Heavy hitters in the angiogenesis arena. J. Clin. Inv. 2001, 108, 349-355.
4. Sasisekharan, R., Shriver, Z.; Venkataraman, G.; Narayanasami, U. Roles of heparan sulfate glycosaminoglycans in cancer. Nature Rev./Cancer 2002, 2, 521-528.
5. Fareed, J.; Hoppensteadt, D. A.; Bick, R. L. An update on heparins at the beginning of the new millennium. Seminars Thromb. Hemost. 2000, 26 (1), 5-21.
6. Smolenburg, S.; Van Noorden, C. J. The complex effects of heparins in cancer progression and metastasis in experimental studies. Pharmacol. Rev. 2001, 53, 93-105.
7. Vlodavsky, I.; Friedman, Y.; Elkin, M.; Aingorn, H.; Atzmon, R.; Ishai-Michaeli, R.; Bitan, M.; Pappo, O.; Petretz, T.; Michal, I.; Spector, L.; Pecker, I. Nature Med. 1999, 5, 793-802.
8. Borsig, L.; Wong, R.; Feramisco, J.; Nadeau, D. R.; Varki, N. M.; Varki, A. Heparin and cancer revisited: Mechanistic connections involving platelets, carcinoma mucins, and tumor metastasis. Proc. Natl. Acad. Sci. U.S.A., 2001, 98, 3352-3357.
9. Lapierre, F.; Holme, K.; Lam, L.; Tressler, L. J.; Storm, N.; Wee, J.; Stack, R. J.; Castellot, J.; Tyrrell, D. J. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, antitumor and anti-metastatic properties. Glycobiology 1996, 6, 355-366.
10. Casu, B.; Lindahl, U. Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem. 2001, 57, 159-206.
11. Capila, I.; Linhardt, R. J. Heparin-protein interactions. Angew. Chem. (Int. Ed.) 2002, 41, 390-412.
12. Cross, M. J.; Claesson-Welsh, L. FGF and VEGF function in angiogenesis: Signaling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 2001, 22, 201-207.
13. Coltrini, D.; Rusnati, M.; Zoppetti, G.; Oreste, P.; Isacchi, A.; Caccia, P.; Bergonzoni, L.; Presta, M. Biochemical bases of the interaction of human fibroblast growth factor with glycosaminoglycans. Eur. J. Biochem. 1993, 214, 51-58.
14. Pellegrini, L. Role of heparan sulfate in fibroblast growth factor signaling: A structural view. Curr. Opin. Struct. Biol. 2001, 11, 629-634.
15. Guimond, S.; Maccarana, M.; Olvin, B. B.; Lindahl, U.; Rapraeger, A. C. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). J. Biol. Chem. 1993, 268, 23906-23914.
16. Ornitz D. M.; Herr A. B.; Nilsson, M.; Westman, J.; Svahn, C.-M.; Waksman, G. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science 1995, 268, 432-436.
17. Lundin, L.; Larsson, H.; Krueger, J.; Kanda, S.; Lindahl, U.; Salvimirta, M.; Claesson-Welsh, L. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogeneity and angiogenesis. J. Biol. Chem. 2000, 275, 24653-24660.
18. Jaseja, M.; Rej, R. N.; Sauriol, F.; Perlin, A. S. Novel regio- and stereoselective modifications of heparin in alkaline solution. Nuclear magnetic resonance spectroscopic evidence. Can. J. Chem. 1989, 67, 1449-1456.
19. Rej, R. N.; Perlin, A. S. Base-catalyzed conversion of the α-L-iduronic acid 2-sulfate unit into a unit of α-L-galacturonic acid, and related reactions. Carbohydr. Res. 1990, 200, 427-447.
20. Piani, S.; Casu, B.; Marchi, E. G.; Torri, G.; Ungarelli, F. Alkali-induced optical rotation changes in heparins and heparan sulfates, and their relation to iduronic acid-containing sequences. J. Carbohydr. Chem. 1993, 12, 507-521.
21. Casu, B.; Diamantini, G.; Fedeli, G.; Mantovani, M.; Oreste, P.; Pescador, R.; Porta, R.; Torri, G.; Zoppetti, G. Retention of antilipemic activity by nonanticoagulant periodate-oxidized heparins. Arzneim-Forsch. (Drug Res.) 1986, 36, 637-642.
22. Casu, B.; Guerrini, M.; Naggi, A.; Perez, M.; Torri, G.; Ribatti, D.; Carminati, P.; Giannini, G.; Penco, S.; Pisano, C.; Belleri, M.; Rusnati, M.; Presta, M. Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor-2 and angiogenesis inhibitors. Biochemistry 2002, 41, 10519-10528.
23. 13C nuclear magnetic resonance spectroscopy for characterization of heparins. Seminars Thromb. Hemost. 2001, 27, 473-482.
24. Linker, A.; Hovingh, P. Degradation of heparin as a tool for structural analysis. In Heparin: Structure, cellular functions, and clinical applications; McDuffie, N. M., Ed.; Academic Press: New York, 1979, pp 3-24.
25. Leali, D.; Belleri, M.; Urbinati, C.; Coltrini, D.; Oreste, P.; Zoppetti, G.; Ribatti, D.; Rusnati, M.; Presta, M. Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. J. Biol. Chem. 2001, 276, 37900-37908.
26. Ribatti, D.; Goulandris, A., Bastaki, M., Vacca, A., Iurlaro, M.; Roncali, L.; Presta, M. New model of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: The gelatin sponge/chorioallantoic membrane assay. J. Vasc. Res. 1997, 34, 455-463.
27. Ribatti, D.; Urbinati, C.; Nico, B.; Rusnati, M.; Roncali, L.; Presta, M. Endogeneous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev. Biol. 1995, 170, 39-49.
28. Still, W. C.; Tempczyk, A.; Hawlely, R.; Hendrickson, T. A general treatment of solvation for molecular mechanics. J. Am. Chem. Soc. 1990, 112, 6127-6129.
29. Faham, S.; Hileman, R. E.; Fromm, J. R.; Linhardt, R. J.; Rees, D. C. Heparin structure and interactions with basic fibroblast growth factor. Science 1996, 271, 1116-112.
30. Guarnieri, F.; Still, W. C. A rapidly convergent simulation method: Mixed Mo Carlo/Stochastic Dynamics. J. Comput. Chem. 1994, 15, 1302-1310.
31. Plotnikov, A. N.; Schlessinger; J., Hubbard; S. H., Mohammadi, M. Structural basi for FGF receptor dimerization and activation. Cell 2000, 9, 413-424.
32. Stauber, D. J.; Di Gabriele; A. D., Hendrikson, W. A. Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 49-54.
33. Casu, B. Structure, shape and functions of glycosaminoglycans. In New Trends in Hemostasis; Harenberg, J., Heene, D. L., Stehle, G., Schettler, G., Eds.; Springer Verlag: Heidelberg, 1990; pp 2-11.
34. Naggi, A.; Perez, M.; Torri, G.; Penco; S., Pisano; C., Giannini, G.; Vlodavsky, I.; Casu, B. Commun. XXI Intern. Carbohydr. Symposium, Cairns, 2002.
35. Holme, K. R.; Liang, W.; Yang, Z.; Lapierre, F.; Shaklee, P. N.; Lam, L. A detailed evaluation of the structural and biological effects of alkaline 2-O-desulfation reactions of heparin. In Nonanticoagulant action of glycosaminoglycans; Harenberg, J.; Casu, B., Eds; Plenum Press: New York, 1996; pp 139-162.
36. Conrad, H. E.; Guo, Y. Structural analysis of periodate oxidized heparin. In Heparin and related polysaccharides; Lane, D. A., Björk, I., Lindahl, U., Eds.; Plenum Press: New York, 1992; pp 31-36.
37. th EORTC NCI-AACR Symposium 2002, A 229.
38. Isacchi, A.; Statuto, M.; Chiesa, L.; Bergonzoni, L.; Rusnati, M.; Sarmietos, P.; Ragnotti, G.; Presta, M. A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 2628-2632.
39. Harenberg, J.; De Vries, J. X. Characterization of heparins by high-pressure size-exclusion liquid chromatography. J. Chromatogr. 1983, 261, 287-292.
40. Wessler, E. Electrophoresis of acidic glycosaminoglycans in hydrochloric acid: A micro method for sulfate determination. Anal. Biochem. 1971, 41, 67-69.
41. Keary, C. M. Charaterization of Methocel cellulose ethers by aqueous SEC with multiple detectors. Carbohydr. Polym. 2001, 45, 293-303.
42. Casu, B.; Gennaro, U. A simple conductometric method for determining the sulfate and carboxylate groups in heparins and chondroitin sulfates. Carbohydr. Res. 1975, 39, 168-176.
43. G. Venkataraman; Z. Shriver; Davis, J. C.; Sasisekharan, R. Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 1892-1897.
44. Cifonelli, J. C. Reaction of heparitin sulfate with nitrous acid. Carbohydr. Res. 1968, 8, 233-242.
45. Hoffman, J.; Larm, O.; Scholander, E. A new method for covalent coupling of heparin and other glycosaminoglycans to substances containing primary amino groups. Carbohydr. Res. 1983, 117, 328-331.
46. Inohue, Y., Nagasawa, K. Selective N-desulfation ofheparin with dimethylsulphoxide containing water or methanol. Carbohydr. Res. 1976, 46, 87-95.
47. Nagasawa, K.; Inoue, Y.; Kamata, T. Solvolytic desulfation of glycosaminoglycuronan sulfates with dimethyl sulphoxide containing water or methanol. Carbohydr. Res. 1977, 58, 47-55.
48. Homans, S. W. A molecular mechanical force field for the conformational analysis of oligosaccharides: Comparison of theoretical and crystal structures of Man-α1,3-Man-β1,4-GlcNAc. Biochemistry 1990, 29, 9110-9118.
49. Esko, J. D. Genetic analysis of proteoglycan structure, function and metabolism. Curr. Opin. Cell. Biol. 1991, 3, 805-816.